LexDanaLexDanabeta
Inventor

Mark Wall

Inventor
Lansdale, PA, US

Overview

36→
Patents
2006–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 36 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes27%
C07DHeterocyclic compounds27%
C12NMicroorganisms or enzymes6%
C07KPeptides4%
A61NElectrotherapy3%
C07CAcyclic or carbocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
10,875,902Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof202010,858,413Immunoglobulins and uses thereof202010,787,495Immunoglobulins and uses thereof202010,653,673Substituted imidazoles as N-type calcium channel blockers202010,640,544Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors202010,428,134Immunoglobulins and uses thereof201910,077,241Tetrahydro-benzoimidazolyl modulators of TGR520189,974,775Substituted imidazoles as N-type calcium channel blockers20189,526,731'Method of inhibiting C-KIT kinase'20169,452,996'Inhibitors of c-fms kinase'20169,453,002'Substituted imidazoles as N-type calcium channel blockers'20169,434,693'Substituted pyrazoles as N-type calcium channel blockers'20169,403,804'Inhibitors of c-fms kinase'20169,394,289'Inhibitors of c-fms kinase'20169,296,726'Inhibitors of c-fms kinase'20169,221,797'Inhibitors of c-fms kinase'20158,933,091'Method of inhibiting C-KIT kinase'20158,901,314'Substituted pyrazoles as N-type calcium channel blockers'20148,895,584'Inhibitors of c-fms kinase'20148,859,602'Inhibitors of c-fms kinase'20148,815,867'Inhibitors of c-fms kinase'20148,759,347'Inhibitors of C-FMS kinase'20148,697,716'Method of inhibiting C-KIT kinase'20148,674,100'Inhibitors of C-FMS kinase'20148,497,376'Inhibitors of c-fms kinase'20138,481,564'Inhibitors of c-fms kinase'20137,973,035'Inhibitors of C-FMS kinase'20117,795,279'Method of inhibiting FLT3 kinase'20107,705,042'Class of arylamide compounds useful as inhibitors of c-fms kinase'20107,662,837'Inhibitors of c-fms kinase'20107,645,755'Inhibitors of c-fms kinase'20107,414,050'Inhibitors of c-fms kinase'20087,326,788'Quinolinone derivatives as inhibitors of c-fms kinase'20087,138,530'Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions'20067,109,354'Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions'20067,030,112'Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2014Based in Harleysville, PA, US· patent location history
2008–2020Patents assigned to JANSSEN PHARMACEUTICA NV (33)· patent assignee history
2008–2014Based in Flourtown, PA, US· patent location history
2013–2014Patents assigned to CHEN JINSHENG (6)· patent assignee history
2013–2014Patents assigned to ILLIG CARL R (6)· patent assignee history
2013–2014Patents assigned to MEEGALLA SANATH K (5)· patent assignee history
2013–2014Patents assigned to BALLENTINE SHELLEY K (4)· patent assignee history
2014–2020Based in Lansdale, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JANSSEN PHARMACEUTICA NV332008–2020
CHEN JINSHENG62013–2014
ILLIG CARL R62013–2014
MEEGALLA SANATH K52013–2014
BALLENTINE SHELLEY K42013–2014
Locations
LocationPatentsSpan
Lansdale, Pennsylvania, US202014–2020
Flourtown, Pennsylvania, US82008–2014
Harleysville, Pennsylvania, US82006–2014